GC Biopharma’s Hunter Syndrome Treatment ‘Hunterase’ Receives Drug Approval in India and Taiwan
- Secures approval for 'Hunterase IV' in India and both 'Hunterase IV & ICV' in Taiwan, accelerating expansion into the Asian rare disease market YONGIN, South Korea, Aug. 24, 2026 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global…